STAT Plus reports, “Almost no one is prescribing [aducanumab] Aduhelm, the controversial new Alzheimer’s treatment that roiled the health care landscape when regulators approved it this summer.” Major healthcare systems including “the Cleveland Clinic made it clear almost immediately that they wouldn’t offer the new therapy, citing a lack of convincing evidence that the drug actually helps treat Alzheimer’s disease.” STAT “has identified another 15 university-affiliated hospitals that aren’t offering the drug, including Johns Hopkins, University of California Los Angeles, and the University of Michigan.”

From the news release of the American Association for Justice.